AstraZeneca PLC (LON:0A4J)
London · Delayed Price · Currency is GBP · Price in USD 82.89
-1.66 (-1.96%)
At close: Oct 29, 2025
AstraZeneca Market Cap
AstraZeneca has a market cap or net worth of 212.02 billion as of December 19, 2025. Its market cap has increased by 30.10% in one year.
Market Cap
212.02B
Enterprise Value
230.29B
Revenue
43.24B
Ranking
n/a
PE Ratio
30.32
Stock Price
82.89
Market Cap Chart
Since May 28, 1993, AstraZeneca's market cap has increased from 4.55B to 212.02B, an increase of 4,559.27%. That is a compound annual growth rate of 12.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 212.02B | 30.64% |
| Dec 31, 2024 | 162.29B | -1.22% |
| Dec 29, 2023 | 164.29B | -5.48% |
| Dec 30, 2022 | 173.83B | 29.30% |
| Dec 31, 2021 | 134.44B | 39.83% |
| Dec 31, 2020 | 96.14B | -3.67% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 210.09B |
| HSBC Holdings | 197.25B |
| Shell | 152.32B |
| Unilever | 108.09B |
| Rio Tinto Group | 98.82B |
| British American Tobacco p.l.c. | 93.12B |
| Rolls-Royce Holdings | 92.24B |
| GSK plc | 72.73B |